Ocular Therapeutix™ to Participate at Three Upcoming Investor Conferences

by Business Wire • 2022/11/08 • 0 Comments

BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate at the following conferences: Jefferies London Healthcare Conference Fireside Chat Date: Wednesday November 16, 2022 Fireside Chat Time: 2:05 PM GMT Location: Waldorf Hilton, London, UK BTIG Virtual Ophthalmology Day 2022 Fireside

← Physical fitness associated with reduced risk for allergic conjunctivitis in children

Aviceda Announces Additional World-Class Members to its Clinical Advisory Board to Support its Clinical Development Strategy in Ophthalmology →

Post navigation